Many of Australia’s top brokers have been busy adjusting their financial models again, leading to the release of a large number of broker notes this week.
Three broker buy ratings that have caught my eye are summarised below. Here’s why brokers think these ASX shares are in the buy zone:
Cochlear Limited (ASX: COH)
According to a note out of Morgan Stanley, its analysts have retained their overweight rating and $229.00 price target on this hearing solutions company’s shares. The broker notes that its industry research shows that most U.S. patients which postponed implant procedures at the height of the pandemic have now had them implanted. It feels this supports the view that trading conditions are returning to pre-COVID 19 levels. In addition, its analysts found that there is a preference for Cochlear’s product among patients due to their quality and design. The Cochlear share price is trading at $228.54 this afternoon.
Collins Foods Ltd (ASX: CKF)
Analysts at Morgans have retained their add rating and lifted the price target on this quick service restaurant operator’s shares to $10.80. According to the note, the broker believes that Collins Foods’ KFC and Taco Bell restaurants will benefit from a return to normality following the release of an effective COVID-19 vaccine. This follows news that Pfizer has had very positive results from its phase 3 trial. The Collins Foods share price is changing hands for $10.01 on Wednesday.
Pushpay Holdings Ltd (ASX: PPH)
A note out of Goldman Sachs reveals that its analysts have retained their conviction buy rating and $10.35 price target on this donation management and community engagement platform provider’s shares. It notes that at the broker’s recent tech forum, Pushpay revealed that it is observing early indications of stickiness with digital giving. It also expects the integration of Church Community Builder to help it capture a greater share of the wallet. This is particularly the case among larger churches which see value in a full service one stop shop offering. The Pushpay share price is fetching $7.17 this afternoon.
Man who said buy Kogan shares at $3.63 says buy these 3 ASX stocks now
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.
Find out the names of our 3 Post COVID Stocks – For FREE!
*Returns as of 6/8/2020
More reading
- 2 fast-growth ASX tech shares that are being sold off
- Pushpay (ASX:PPH) investor day presentation: any updates to recover its share price?
- 3 mid-cap ASX shares with recent price pullbacks
- Reasons to be confident and cautious as ASX shares are bouncing back
- 2 ASX healthcare shares to buy today
James Mickleboro owns shares of Collins Foods Limited. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Cochlear Ltd. and PUSHPAY FPO NZX. The Motley Fool Australia has recommended Cochlear Ltd., Collins Foods Limited, and PUSHPAY FPO NZX. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
The post Top brokers name 3 ASX shares to buy today appeared first on Motley Fool Australia.
from Motley Fool Australia https://ift.tt/3kk8sr4
Leave a Reply